Our Members

GSK

 

About Uniting science, technology and talent to get ahead of disease together.
How we share on the AMR Register To obtain GSK’s AMR surveillance data for analysis, researchers should use the AMR Register platform to submit a request. The anonymized data will then be made available to the researcher to download. Data for ongoing surveillance programs will be updated annually.
Programs Listed for Sharing AMR surveillance data available on the AMR Register:

  • SOAR 201818 – Results from the Survey of Antibiotic Resistance (SOAR) 2014-2016 in Bulgaria, Romania, Serbia, Croatia, Russia, Czech Republic, Ukraine, the Slovak Republic and Greece
  • SOAR 201910 – Results from the Survey of Antibiotic Resistance (SOAR) 2015-2018 in Argentina, Cambodia, Chile, Costa Rica, Kenya, Kuwait, Lebanon, Morocco, Pakistan, Philippines, Saudi Arabia, Singapore, Tunisia, Turkey, Ukraine, Vietnam
  • SOAR 207965 – Results from the Survey of Antibiotic Resistance (SOAR) 2018-2021 in India, Italy, Kuwait, Pakistan, Spain, Tunisia, Türkiye, Ukraine, United Arab Emirates, and Vietnam
What information will be provided Where available, the following data and information are provided for each dataset:

  • Raw dataset. This is the dataset containing the anonymized isolate level data collected during the study. The dataset can be downloaded.
  • Program description. Information about how the data were collected is provided on the program pages.
  • Links to Publications. Links to journal publications based on the data collected are provided on the program pages.
Data Request Review Process Researchers can request access to our datasets by providing the purposes of the analysis and a brief description of the research project. The research proposal is reviewed by the data contributor.
Review Criteria for Data Requests If a data request competes with the GSK’s publication plan, or duplicates analyses already published, GSK will decline the research proposal and inform the researcher accordingly.

Pursuant to the US DOJ Final Rule – Preventing Access to Americans’ Bulk Sensitive Personal Data and United States Government-Related Data by Countries of Concern (28 CRF Part 202)

  • Requests from Countries of Concern or Covered Persons for accessing datasets are reviewed on a case-by-case basis.
  • If approved, requests from Countries of Concern or Covered Persons for accessing datasets that include sensitive personal data of US persons will have that data removed before sharing.
Questions or enquiries Please send any questions or enquiries to amr@vivli.org
GSK’s Register or Website www.gsk-studyregister.com/en/trial-details/?id=201818
Back to Our Members